| George Tran, PHARMD | |
|
2533 Crestline Ter, Alhambra, CA 91803-4303 | |
| (626) 627-4780 | |
| Not Available |
| Full Name | George Tran |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 2533 Crestline Ter, Alhambra, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598439721 | NPI | - | NPPES |
| 56236 | Other | CA | CALIFORNIA STATE BOARD OF PHARMACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 56236 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| George Tran, PHARMD 2533 Crestline Ter, Alhambra, CA 91803-4303 Ph: (626) 627-4780 | George Tran, PHARMD 2533 Crestline Ter, Alhambra, CA 91803-4303 Ph: (626) 627-4780 |
News Archive
Capitalizing on the continued strong growth of Indiana's life sciences industry and an active venture capital market, leaders from BioCrossroads, Eli Lilly and Company, Indiana State Teachers Retirement Fund, Indiana University, Purdue University, the University of Notre Dame, Richard M. Fairbanks Foundation, and Credit Suisse today announced the establishment of the INext Fund, a $58 million venture capital fund of funds.
Keryx Biopharmaceuticals today announced completion of patient enrollment in the long-term study component of its Phase 3 registration program of Zerenex, the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis.
According to a recent study published in JAMA Neurology, Northwestern Medicine scientists have examined more than a century of data of the genetic makeup of ataxias, a neurodegenerative disorder, to better understand the different forms of this devastating disease and how it affects patients.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
A tiny ultrasound device that helps dissolve blood clots is showing promise in breaking up potentially deadly pulmonary embolisms, blockages of blood vessels in the lungs that can occur after long plane rides, surgery and extended bed rest.
› Verified 1 days ago
Phuong Lien Ngo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 69 E Main St, Alhambra, CA 91801 Phone: 626-300-8049 | |
Dr. Andrew Duong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 S Curtis Ave Apt E, Alhambra, CA 91801 Phone: 626-800-8883 | |
Dr. Heena R Chollera, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 E Commonwealth Ave Apt F, Alhambra, CA 91801 Phone: 909-802-0978 | |
Raymond T Chan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 69 E Main St, Alhambra, CA 91801 Phone: 626-300-8047 | |
Chia Fang Chang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 88 S Garfield Ave Unit 128, Alhambra, CA 91801 Phone: 240-687-2659 | |
Dru Elizabeth Lezina, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave, Alhambra, CA 91803 Phone: 855-885-2600 | |
Angela Hyunjung Choi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 305 N 3rd St Apt B, Alhambra, CA 91801 Phone: 626-542-5415 |